Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab for Glaucoma Bleb Revision
NCT00853073Phase 3Completed
- Sponsor
- Wills Eye Hospital
- Start
- Feb 2009
- Primary completion
- Jan 2012
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of bevacizumab in Glaucoma, sponsored by Wills Eye Hospital. Started Feb 2009; status: completed.
02
Drugs
bevacizumab
03
Conditions
Glaucoma
Beyond the preview
Go deeper on NCT00853073.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00853073.